Tumor-initiating activity of 4-fluoro-7,12-dimethylbenz[a]anthracene and 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice

Carcinogenesis

Volumn 3, Issue 6, 1982, Pages 651-655

  Digiovanni, John ^a   Diamond, Leila ^a   Singer, Jody M ^a   Daniel, F Bernard ^b   Witiak, Donald T ^c   Slaga, Thomas J ^d  

^a WISTAR INSTITUTE   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4 TETRAHYDRO 7,12 DIMETHYLBENZ[A]ANTHRACENE; 4 FLUORO 7,12 DIMETHYLBENZ[A]ANTHRACENE; 7,12 DIMETHYLBENZ[A]ANTHRACENE DERIVATIVE; PHORBOL 13 ACETATE 12 MYRISTATE; TIOGUANINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; MOUSE; PAPILLOMA; STRUCTURE ACTIVITY RELATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BENZ(A)ANTHRACENES; BIOTRANSFORMATION; CARCINOGENS; FEMALE; MICE; MICE, INBRED STRAINS; MUTAGENS; NEOPLASMS, EXPERIMENTAL; SKIN NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0019933638     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/3.6.651     Document Type: Article

References (46)

1. Freudenthal, R., and Jones, P.W. (eds.), Raven Press, NY; and Dipple, A., Polynuclear aromatic hydrocarbons, in Chemical Carcinogenesis (Searle, C.B., ed.), American Chanical Society Monograph No. 173, American Chemical Society, 1976, pp. 253-314.
2. Jerina, J.D.M., Lehr, R., Schaefer-Ridder, M., Yagi, H., Karle, J.M., Thak-ker, DJC, Wood, A.W., Lu, A.Y.H., Ryan, D., West, S., Levin, W., and Con-ney, A.H. (1977), Bay region epoxides of dihydrodiols: a concept explaining the mutagenic and carcinogenic activity of benzo[a]pyrene and benzfajanthra-cene, in Hiatt, H.H., Watson, J.D., and Winsten.JA. (eds.), Origins of Human Cancer, Cold Spring Harbor Laboratory, NY, pp. 639-658.
3. Moschei, R.C., Baird, W.M., and Dipple, A. (1977), Metabolic activation of the carcinogen 7,12-dimethylbenzfa)anthracene for DNA binding, Bio-chem. Biophys. Res. Commun., 76, 1092-1098.
4. Baird, WJvl., and Dipple, A. (1977), Photosensitivity of DNA-bound 7,12-dimethylbenz(a]anthracene, Int. J. Cancer, 20, 427-431.
5. Dipple, A., and Nebzydosk, M.A. (1978), Evidence for the involvement of a tflol-epoxide in the binding of 7,12-dimethylbenz(a]anthracene to DNA in cells in culture, Chem.-Biol. Interactions, 20, 17-26.
6. Dipple, A., Tomaszewslo, J.E., Moschd, R.C., Bigger, C.A.H., Nebzy-doskj, J.A., and Egan, M. (1979), Comparison of metabolism-mediated binding to DNA of 7-hydraxymethyl-12-methylbenzfaJanthracene and 7,12-di-methylbenzfajanthracene, Ccncer Res., 39, 1154-1158.
7. Bigger, C.A.H., Toraaszewski, J.E., and Dipple, A. (1978), Differences between products of binding of 7,12-dimethylbeiizfaJanthracene to DNA in mouse skin and in rat liver, Biochem. Biophys. Res. Commun., 80, 229-235.
8. Vigny, P., Duquesne, M., Coulomb, H., Tiemey, B., Grover, P.L., and Sims, P. (1977), Fluorescence spectral studies on the metabolic activation of 3-methylcholanthrene and 7,12-dimethyl ben z(a)anthracene in mouse skin, FEBS Lett., 82, 278-282.
9. Vigny, P., Kindts, M., Cooper, C.S., Grover, P.L., and Sims, P. (1981), Fluorescence spectra of nucleoside hydrocarbon adducts formed in mouse skin treated with 7,12-dimethylbenzfaJanthracene, Ctrcinogenesis 2, 115-119.
10. Ivanovic, V., Geadntov, N.E., Jeffrcy, A.M., Fu, P.P., Harvey, R.G., and Weinstein, I.B. (1978), Cdl and raicrosome mediated binding of7,12-di-methylbenz[a]anthracene to DNA studied by fluorescence spectroscopy. Cancer Lett., 4, 131-140.
11. MacNicofl, A.D., Burden, P.M., Ribeiro, O., Hewer, A., Grover, J.L., and Sms, P. (1979), The formation of dihydrodiols by the chemical or enzymatic oxidation of 7-hydraxymethyl-12-methylbenz(a)anthracene and the possible role of hydroxymethyi-dihydrodiols in the metabolic activation of 7.12- dimethylbenz[a]anthracene, Chem.-Biol. Interactions, 26, 121-132.
12. Malaveille, C., Bartsch, H., Tiemey, B., Grover, P.L., and Sms, P. (1978), Microsame-mediated mutagenesis of the dihydrodiols of 7,12-di-methylbenz(ajanthracene: high mutagenic activity of the 3,4-dihydrodiol, Biochem. Biophys. Res. Contmun., 83, 1468-1473.
13. Wislocki, T.G., Gadek, K.M., Chou, M.W., Yang, S.K., and Uvk, Y.H. (1980), Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenzfa]anthracene and its hydroxymethyl derivatives, Cancer Res., 40, 3661-3664.
14. Huberman, E., Chou, M.W., and Yang, S.K. (1979), Identification of 7.12- dimethyfbenz(a]anthracene metabolites that lead to mutageness in mammalian cells, Proc. Ndl. Acad. Sci. USA, 76, 862-866.
15. Slaga, T.J., Gleason, G.L., DiGiovanni, J., Sukumaran, K.B., and Harvey, R.G. (1979), Potent tumor initiating activity of the 3,4-dihydrodiol of 7.12- dimethylbenz(a]anthracene in mouse skin. Cancer Res., 39, 1934-1936.
16. Wisloclri, P.G., Juliana, W., MacDonald, J.S., Chou, M.W., Yang, S.I., and Lu, A.-Y.H. (1981), Tumorigenicity of 7,12-dimethyibenz(a]anthra-caie, its hydroxymethylated derivatives and selected dihydrodiols in the newborn mouse, Carcinogenesis, 2, 511-514.
17. Slaga, TJ., Huberman, E., DiGiovanni, J., Gleason, Gl., and Harvey, G. (1979), The importance of the “bay region” diol-epoxide in 7,12-di-methylbenz(a]anthracene skin tumor initiation and mutagenesis, Ccncer Lett., 6, 213-220.
18. Hubermanf, Slaga T.J. (1979), Mutagenicity and tumor initiating activity of fhiorinated derivatives of 7,12-dimethylbenz(a]anthraccene, Cancer Res., 39, 411-414.
19. Yang, SJC., Chou, M.W., and Rofler, P.P. (1979), Potential proximate carcinogens of 7,12-dimethyl benzfajanthracene: characterization of two metabolically formed trans-3,4-dihydrodiob, J. Am. Chem. Soc., 101, 237-239.
20. Chou, M.W., and Yang, S.K. (1978), Identification of four trans-3,4-di-hydrodiol metabolites of 7,12-dimethylbenzfa]anthracene and their in vitro DNA-binding activities upon further metabolism, Proc. Natl. Acad. Sa. USA, 75, 5466-5470.
21. Chou, Al.W., Yang, S.K., Sydor, W., and Yang, C.S. (1981), Metabolism of 7,12-dimethylbenzfaJanthracene and 7-hydroxymethyi-12-methylbenzfa]- anthracene by rat liver nuclei and microsomes, Cancer Res., 41, 1559-1564.
22. Inbasekaran, M.J., Witiak, D.T., Barone, K., and Loper, J.C. (1980), Synthesis and mutagenicity of A-ring reduced analogues of 7,12-dimethyl-benzfajanthracene, J. Med. Chem., 23, 278-281.
23. DiGiovanni, J., Slaga, T.J., and Boutwell, R.K. (1980), Comparison of the tumor initiating activity of 7,12-dimethyibenzfaJanthracene and benzofajpyrene in female SENCAR and CD-I mice, Carcinogenesis, 1, 381-389.
24. Huberman, E., and Sachs, L. (1974), Cdl-mediated mutagenesis of mammalian cells with chemical carcinogens, Ini. J. Cancer, 13, 326-333.
25. Baird, W.M., O’Brien, T.G., and Diamond, L. (1981), Comparison of the metabolism of benzo[a]pyrene and its activation to biologically active metabolites by low passage hamster and rat embryo cells, Ctrcinogenesis 2, 81-88.
26. Harvey, R.G., and Dunne, F.B. (1978), Multiple regions of metabolic activation of carcinogenic hydrocarbons, Nature, 273, 566-568.
27. MacNtcoll, A.D., Cooper, CR., Ribeiro, O., Govasi, P.G., Hewer, A., Walsh, C., Grover, P.L., and Sims, P. (1979), The involvement of a non-“bay region” diol-epoxide in the formation of benz(a]anthracene DNA adducts in a rat liver microsomal system, Biochem. Biophys. Res. Commun., 91,490-497.
28. Cooper, C.S., Ribeiro, O., Hewa, A., Waldi, C., Pal, K., Grover, P.L., and Sims, P. (1980), The involvement of a “bay-region” and a non-“bay region” diol-epoxide in the metabolic activation of benzfajanthracene in mouse skin and in hamster embryo cells, Carcinogenesis, 1, 233-243.
29. MacNico, A., Cooper, CR., Ribeiro, O., Pal, J.C., Hewer, A., Grover, P.L., and Sims, P. (1981), The metabolic activation of benzfajan-thracene in three biological systems, Ccncer Lett., 11, 243-249.
30. Yang, S.K., Easton, G.D., and Chou, M.W. (1980), Multiple activation pathways of 7,12-dimethylbenz[ajanthracene, in Coon, M.J., Conney, A.H., Estabrook.R.W., GelboinXXV., Gillette, J.R., and O’BrienR.J. (eds.), Microsomes, Drug Oxidations, end Chemical Ctrcinogenesis, Vol.2, Academic Press, NY, pp. 1185-1188.
31. Cavalieri, J.E., Sinha, D., and Rogan, E. (1980), Rat mammary gland versus mouse skin: different mechanisms of activation of aromatic hydrocarbons, in Bjorseth.A., and Dennis, A. J. (eds.), Polynuclear A romatic Hydrocarbons: Chemistry and Biological Effects, Batidle Press, Columbus, OH, pp. 215-231.
32. Slaga, T.J., Huberman, X., Selkirk, JJC, Harvey, R.G., and Bracken, WÜ. (1978), Carcinogenicity and mutagenicity of benzfajanthracene diols and di of-epoxides, Cancer Res., 38, 1699-1704.
33. Slaga, T.J., Gleason, GX., DiGiovanni, J., BoTy, DX., Juchau, M.R., Fu, P.P., SukumaranR.B., and Harvey.R.G. (1979), Tumor iritiating activities of various derivatives of benz(a]anthracene and 7,12-dimethylbenzfa]- anthracene in mouse skin, in Jones.P.W., and Leber, P. (eds.), Polynuclear AromOic Hydrocarbons, Ann Arbor Science Publishers, Inc, Ann Arbor, MI, pp. 753-764.
34. Miller, JA., and Miller, X.-C. (1963), The carcinogenidties of fluoro-derivalives of 10-methyl-1,2-benzanthracene. II. Substitution of the K region and the 3'-, 6-, and 7- positions, Canco' Res., 23, 229-239.
35. Danid, F.B., Wong, L.K., Oravec, C.T., Cazer, F.D., Wang, C’L.A., D’Ambrosio, M.D., Hart, R.W., and Witiak, D.T. (1979), Biochemical studies on the metabolism and DNA-binding of DMBA and some of its monofluoro derivatives of varying carcinogenicity, in Jones.P.W., and Leber, P. (eds.). Polynuclear Aromatic Hydrocarbons, Ann Arbor Science Publishers, Inc., Ann Arbor, MI, pp. 855-883.
36. Scribner, N.K., and Scribner, J. (1980), Separation of initiating and promoting effects of the skin carcinogen 7-bromomethyibenzfajanthracene, Carcinogenesis, 1, 97-100.
37. Flesher, J.W., and Sydnor, K.L. (1973), Possible rote of 6-hydroxy-methyibenzofajpyrene as a proximate carcinogen of benzopyrene and 6-methylbenzo[a]pyrene, Int. J. Canco, 11, 433-437.
38. Siaga, T.J., Bracken, W.M., Viaje, A., Berry, D.L., Fischer, S.M., and Miller, D.R. (1978), Lack of involvement of 6-hydroxymethyIation in ben-zofajpyrene skin tumor initiation, J. Natl. Cancer Inst., 61, 451-455.
39. Daly, J.W., Jerina, D.M., and Witkop, X. (1973), Arene oxides and the NIH shift: the metabolism, toxidty and cardnogenidty of aromatic compounds, Experientia, 28, 1129-1149.
40. Jerina, D.M., and Daly, J.W. (1974), Arene oxides: a new aspect of drug metabolism, Science, 185, 573-582.
41. Yang, S.K., Chou, M.W., Weems, H.B., and Fu, P.P. (1979), Enzymatic formation of an 8,9-diol from 8-methylbenzfaJanthracene, Biochem. Biophys. Res. Commun., 90, 1136-1141.
42. Wood, A.W., Levin, W., and Lu, A.Y. (1977), Structural requirements for the metabolic activation of benzofajpyrene to mutagenic products: effects of modification in the 4,5-, 7,8-, and 9,10-positions, Mol. Pharmacol., 13, 1116-1125.
43. Kouri, R.B., Wood, A.W., Levin, W., Rude, J.H., Yagi, H., Mah, H.D., and Jerina, D.M. (1980), Carcinogenicity of benzofajpyrene and thirteen of its derivatives in C3H/fCum mice, J. Natl. Canco Inst., 64, 617-623.
44. Coombs, M.M., Bhatt, T.S., and Young, S. (1979), The carcinogenicity of 15,16-dihydro-l 1-methyl-cydopentafaJphenanthren-17-one, Br. J. Cancer, 40, 914-921.
45. Levin, W., Thakker, D.R., Wood, A.W., Chang, R.L., Lehr, R.E., Jerina, D.M., and Conney, A.H. (1978), Evidence that benzfajanthracene 3,4-diol-1,2-epoxide is an ultimate carcinogen on mouse skin, Cancer Res., 38, 1705-1710.
46. Malaveille, C., Bartsch, H., Tiemey, B., Grover, P.L., and Sims, P. (1978), Microsome-mediated mutagenicities of the dihydrodiols of 7,12-di-methylbenzfajanthracene: high mutagenic activity of the 3,4-dihydrodiol, Biochem. Biophys. Res. Commun., 83, 1468-1473.